Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neuroendocrine Tumor (NET)”

154 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 154 results

Large-scale testing (Phase 3)Looking for participantsNCT06784752
What this trial is testing

Study to Evaluate the Efficacy and Safety of [177Lu]Lu-DOTA-TATE in Patients With Grade 1 and Grade 2 Advanced GEP-NET

Who this might be right for
Somatostatin Receptor Positive (SSTR+)Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET)
Novartis Pharmaceuticals 240
Large-scale testing (Phase 3)Study completedNCT00774930
What this trial is testing

An Efficacy and Safety Study of Somatuline Depot (Lanreotide) Injection to Treat Carcinoid Syndrome

Who this might be right for
Carcinoid Syndrome
Ipsen 115
Not applicableUnknownNCT03812939
What this trial is testing

Recurrence Rates of Type I Gastric Neuroendocrine Tumors Treated With Long-acting Somatostatin Analogs

Who this might be right for
Gastric NET
Peking Union Medical College Hospital 30
Not applicableLooking for participantsNCT06343428
What this trial is testing

Definition of a Multiparametric Prognostic and Predictive System of Classification of NET G3 Patients

Who this might be right for
Neuroendocrine Neoplasm
European Institute of Oncology 20
Post-approval studies (Phase 4)UnknownNCT02621541
What this trial is testing

Nonfunctional Pancreatic NET and PET Imaging

Who this might be right for
Diagnosis
Turku University Hospital 20
Not applicableNot Yet RecruitingNCT07014254
What this trial is testing

Therapeutic Study of 177Lu-CTR-FAPI in Advanced Metastatic Digestive Malignancies

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)Adenocarcinoma of the StomachColorectal Cancer Metastatic+1 more
Xijing Hospital 20
Not applicableStudy completedNCT02481804
What this trial is testing

Optimal Feeding for NET Patients

Who this might be right for
Neuroendocrine Tumor
University Medical Center Groningen 15
Very early researchStudy completedNCT01873248
What this trial is testing

Impact of 68Ga-DOTATATE PET/CT on the Management of Neuroendocrine Tumors: The Referring Physician's Perspective

Who this might be right for
Neuroendocrine Tumors
Jonsson Comprehensive Cancer Center 100
Not applicableLooking for participantsNCT06246630
What this trial is testing

In Vitro Organoid Drug Sensitivity-Guided Treatment for Advanced Pancreatic Neuroendocrine Tumor

Who this might be right for
Advanced Pancreatic Neuroendocrine Tumor
Ruijin Hospital 20
Not applicableLooking for participantsNCT07273409
What this trial is testing

Pancreatic Neuroendocrine Tumour - Optimal Surgical Debulking or Not

Who this might be right for
Pancreatic Neuroendocrine Tumor
Uppsala University 200
Early research (Phase 1)Ended earlyNCT04258592
What this trial is testing

18F-MFBG PET Imaging of the Norepinephrine Transporter in Neural Crest and Neuroendocrine Tumors

Who this might be right for
Neural Crest TumorNeuroendocrine Tumors
Universitaire Ziekenhuizen KU Leuven 6
Not applicableUnknownNCT01763554
What this trial is testing

Review of Medical Records of Patients Who Have Been Treated With Lutetium at the Cross Cancer Institute Between January 2010 and April 30, 2014

Who this might be right for
Neuroendocrine Tumors, NET
AHS Cancer Control Alberta 115
Testing effectiveness (Phase 2)UnknownNCT05199584
What this trial is testing

A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations

Who this might be right for
Solid Tumors With PTCH1 Loss-of-function Mutations
Endeavor Biomedicines, Inc. 44
Testing effectiveness (Phase 2)Study completedNCT01967537
What this trial is testing

Evaluation of 68Gallium-DOTATATE PET/CT for Detecting Neuroendocrine Tumors

Who this might be right for
Neuroendocrine TumorsVon Hippel-Lindau SyndromeHippel-Lindau Disease
National Cancer Institute (NCI) 341
Not applicableLooking for participantsNCT07319416
What this trial is testing

DCEUS to Assess Treatment Response to PRRT in GEP-NET

Who this might be right for
NETRadionucleide TherapyContrast Enhanced Ultrasound
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 30
Early research (Phase 1)Study completedNCT03411915
What this trial is testing

XmAb®18087 in Subjects With NET and GIST

Who this might be right for
Neuroendocrine TumorGastrointestinal Neoplasm
Xencor, Inc. 62
Testing effectiveness (Phase 2)Study completedNCT01262235
What this trial is testing

A Dose Finding Study of TKM-080301 Infusion in Neuroendocrine Tumors (NET) and Adrenocortical Carcinoma (ACC) Patients

Who this might be right for
CancerNeuroendocrine TumorsNET+2 more
Arbutus Biopharma Corporation 68
Testing effectiveness (Phase 2)Active Not RecruitingNCT04711135
What this trial is testing

Study to Evaluate Safety and Dosimetry of Lutathera in Adolescent Patients With GEP-NETs and PPGLs

Who this might be right for
Gastroenteropancreatic Neuroendocrine TumorsPheochromocytomaParaganglioma
Advanced Accelerator Applications 11
Not applicableLooking for participantsNCT06541080
What this trial is testing

Collection of Liquid Biopsy Samples of Neuroendocrine Neoplasms (NEN) Patients - Collection of NET (CollectNET) 2.0, a Study by the BE-FORCE Consortium

Who this might be right for
Neuroendocrine Neoplasms
University Hospital, Antwerp 550
Testing effectiveness (Phase 2)Study completedNCT03220217
What this trial is testing

To Evaluate the Optimal Dose of 68Ga-OPS202 as a PET (Positron Emission Tomography) Imaging Agent in Subjects With Gastroenteropancreatic Neuroendocrine Tumour (GEP-NET)

Who this might be right for
Gastro-Enteropancreatic Neuroendocrine Tumor
Ipsen 29
Load More Results